MEDIASTINAL LYMPH-NODE SIZE IN AN ASIAN POPULATION

Citation
Jg. Murray et al., MEDIASTINAL LYMPH-NODE SIZE IN AN ASIAN POPULATION, British journal of radiology, 68(808), 1995, pp. 348-350
Citations number
16
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
British journal of radiology
ISSN journal
00071285 → ACNP
Volume
68
Issue
808
Year of publication
1995
Pages
348 - 350
Database
ISI
SICI code
Abstract
There is a high incidence of respiratory tuberculosis in the British p opulation of Indian subcontinent (Asian) ethnic origin. Granulomatous diseases can cause long term lymph node enlargement. Separate computed tomography (CT) criteria for normal nodal size could therefore be nec essary when staging thoracic malignancy in Asian patients. The objecti ve of this study was to measure mediastinal lymph node size in an Asia n population, and to correlate nodal size with previous tuberculosis. Chest CT scans on all Asian patients over a 5 year period were reviewe d and those with pulmonary disease, malignancy or grossly distorted an atomy were excluded. The study group consisted of 48 patients (26 male , 22 female) aged 10-75 years (mean 47 years). All nodes were measured and the site of those greater than 7 mm was recorded using the Americ an Thoracic Society (ATS) lymph node map. 81.3% of patients had nodes less than or equal to 7 mm at all ATS stations, 10.4% had nodes of 8-1 0 mm and 8.3% had nodes greater than 10 mm. All nodes measuring more t han 7 mm were in regions 4R, 10R and 7. Fourteen patients had signs of previous tuberculosis, and in this group 50% had nodes greater than 7 mm as compared with 6% in the group with no signs of previous tubercu losis (p < 0.001, gamma(2) test). Despite these differences only four of the 48 patients (8.3%) had nodes greater than 10 mm, which is in ke eping with other general population studies. Thus the generally accept ed size criteria for mediastinal lymph node enlargement (greater than 10 mm) can reasonably be applied to all Asian patients when staging ly mphoma or bronchogenic carcinoma.